N-BenzyloleamideCAS# 101762-87-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 101762-87-2 | SDF | Download SDF |
PubChem ID | 49865534 | Appearance | Powder |
Formula | C25H41NO | M.Wt | 371.6 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Synonyms | Macamide Impurity 2 | ||
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (Z)-N-benzyloctadec-9-enamide | ||
SMILES | CCCCCCCCC=CCCCCCCCC(=O)NCC1=CC=CC=C1 | ||
Standard InChIKey | QHXGFOCPQQADIF-KTKRTIGZSA-N | ||
Standard InChI | InChI=1S/C25H41NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-25(27)26-23-24-20-17-16-18-21-24/h9-10,16-18,20-21H,2-8,11-15,19,22-23H2,1H3,(H,26,27)/b10-9- | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. N-benzyloleamide has pharmaceutical property against exercise-induced fatigue, and this effect can be explained by the modulated energy metabolism and improved antioxidant status. |
Targets | SOD |
N-Benzyloleamide Dilution Calculator
N-Benzyloleamide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6911 mL | 13.4553 mL | 26.9107 mL | 53.8213 mL | 67.2766 mL |
5 mM | 0.5382 mL | 2.6911 mL | 5.3821 mL | 10.7643 mL | 13.4553 mL |
10 mM | 0.2691 mL | 1.3455 mL | 2.6911 mL | 5.3821 mL | 6.7277 mL |
50 mM | 0.0538 mL | 0.2691 mL | 0.5382 mL | 1.0764 mL | 1.3455 mL |
100 mM | 0.0269 mL | 0.1346 mL | 0.2691 mL | 0.5382 mL | 0.6728 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- N-Benzyllinolenamide
Catalog No.:BCN6531
CAS No.:883715-18-2
- E 64d
Catalog No.:BCC1127
CAS No.:88321-09-9
- BI 78D3
Catalog No.:BCC8089
CAS No.:883065-90-5
- CCG 50014
Catalog No.:BCC4897
CAS No.:883050-24-6
- HC 067047
Catalog No.:BCC7861
CAS No.:883031-03-6
- Polygalasaponin F
Catalog No.:BCN2317
CAS No.:882664-74-6
- AMG-47A
Catalog No.:BCC6394
CAS No.:882663-88-9
- Netobimin
Catalog No.:BCC9100
CAS No.:88255-01-0
- R1530
Catalog No.:BCC1879
CAS No.:882531-87-5
- AI-3
Catalog No.:BCC8018
CAS No.:882288-28-0
- P005091
Catalog No.:BCC1287
CAS No.:882257-11-6
- H-Ile-OAll.TosOH
Catalog No.:BCC2963
CAS No.:88224-05-9
- (9Z,12Z)-N-(3-Methoxybenzyl)octadeca-9,12-dienamide
Catalog No.:BCN1316
CAS No.:883715-22-8
- DPDPE
Catalog No.:BCC5758
CAS No.:88373-73-3
- Adrenorphin
Catalog No.:BCC1021
CAS No.:88377-68-8
- 8-Lavandulylkaempferol
Catalog No.:BCN3961
CAS No.:883859-83-4
- 8alpha-(2-Methylacryloyloxy)-1-O-methylhirsutinolide 13-O-acetate
Catalog No.:BCN7106
CAS No.:883872-71-7
- AZD2932
Catalog No.:BCC6388
CAS No.:883986-34-3
- Methyl syringate
Catalog No.:BCN4430
CAS No.:884-35-5
- L-(-)-α-Methyldopa hydrochloride
Catalog No.:BCC4083
CAS No.:884-39-9
- 6,7-Dihydroxycoumarin-4-Acetic Acid
Catalog No.:BCC9205
CAS No.:88404-14-2
- Buparvaquone
Catalog No.:BCC5437
CAS No.:88426-33-9
- (E)-FeCP-oxindole
Catalog No.:BCC6078
CAS No.:884338-18-5
- Murraxocin
Catalog No.:BCN4431
CAS No.:88478-44-8
Effects of macamides on endurance capacity and anti-fatigue property in prolonged swimming mice.[Pubmed:26453017]
Pharm Biol. 2016;54(5):827-34.
CONTEXT: Lepidium meyenii Walp. (Brassicaceae), most commonly known as "maca", has been used as a food or folk medicine to improve vitality in Peru. Previous research demonstrated that lipid-soluble extract from maca improved swimming endurance capacity. Macamides are considered the typical lipid-soluble markers for maca and proved to have several pharmacological properties, such as improving sexual performance and neuroprotective activies. OBJECTIVE: The present study investigates the effects of macamides on endurance capacity and anti-fatigue property in prolonged swimming mice. MATERIALS AND METHODS: The Balb/c mice were divided into seven groups: a control group, low-dose groups of N-benzyllinoleamide, N-Benzyloleamide, and N-benzylpalmitamide, high-dose groups of these macamides. The macamides groups received the commercial products (12 and 40 mg/kg, ig), while the control group received vehicle for 21 d. On the 14th day, the mice were given the weight-loaded swimming test. On the 21st day, the mice were sacrificed immediately after 90 min swimming, and some biochemical parameters were measured. RESULTS AND DISCUSSION: Compared with the control group, exhaustive swimming time was significantly prolonged in high-dose group of N-Benzyloleamide (p < 0.05); the levels of lactic acid (LD), blood ammonia (BA), and lactate dehydrogenase (LDH) were significantly decreased (p < 0.05), whereas the levels of liver glycogen (LG) and non-esterified fatty acid (NEFA) were significantly increased (p < 0.05) in high-dose group of N-Benzyloleamide. The malondialdehyde (MDA) contents in the brain, muscle, and liver were significantly decreased (p < 0.05), whereas superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX) activities in the brain, muscle, and liver were significantly increased in high-dose group of N-Benzyloleamide (p < 0.05). CONCLUSION: The results indicate that N-Benzyloleamide has pharmaceutical property against exercise-induced fatigue, and this effect can be explained by the modulated energy metabolism and improved antioxidant status.